Search Results

There are 26720 results for: content related to: Acute Relapses of Multiple Sclerosis

  1. Acute Relapses of Multiple Sclerosis

    European Handbook of Neurological Management

    F. Sellebjerg, D. Barnes, G. Filippini, R. Midgard, X. Montalban, P. Rieckmann, K. Selmaj, L. H. Visser, P. Soelberg Sørensen, Pages: 433–442, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470753279.ch30

  2. Diltiazem and mibefradil increase the plasma concentrations and greatly enhance the adrenal-suppressant effect of oral methylprednisolone

    Clinical Pharmacology & Therapeutics

    Volume 67, Issue 3, March 2000, Pages: 215–221, Tiina Varis, Janne T. Backman, Kari T. Kivistö and Pertti J. Neuvonen

    Version of Record online : 26 MAR 2000, DOI: 10.1067/mcp.2000.104611

  3. USP Veterinary Pharmaceutical Information Monographs - Anti-inflammatories

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 27, Issue s1, June 2004, Pages: 1–110,

    Version of Record online : 26 MAY 2004, DOI: 10.1111/j.1365-2885.2004.562-572.x

  4. Pharmacokinetics and Pharmacodynamic Response of Methylprednisolone in Premenopausal Renal Transplant Recipients

    The Journal of Clinical Pharmacology

    Volume 44, Issue 9, September 2004, Pages: 1003–1011, Kathleen M. Tornatore, Kristin K. Gilliland-Johnson, Mahfooz Farooqui, Kris A. Reed and Rocco C. Venuto

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004268130

  5. Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity

    Clinical Pharmacology & Therapeutics

    Volume 49, Issue 5, May 1991, Pages: 536–549, Terry E Dunn, Elizabeth A Ludwig, Richard L Slaughter, Daniel S Camara and William J Jusko

    Version of Record online : 21 MAY 1991, DOI: 10.1038/clpt.1991.64

  6. You have free access to this content
    Itraconazole Decreases the Clearance and Enhances the Effects of Intravenously Administered Methylprednisolone in Healthy Volunteers

    Pharmacology & Toxicology

    Volume 85, Issue 3, September 1999, Pages: 29–32, Tiina Varis, Kari T. Kivistö, Janne T. Backman and Pertti J. Neuvonen

    Version of Record online : 25 MAR 2009, DOI: 10.1111/j.1600-0773.1999.tb01059.x

  7. Reduced Methylprednisolone Clearance Causing Prolonged Pharmacodynamics in a Healthy Subject Was Not Associated With CYP3A5*3 Allele or a Change in Diet Composition

    The Journal of Clinical Pharmacology

    Volume 46, Issue 5, May 2006, Pages: 515–526, Dr Su-Jun Lee, Dr William J. Jusko, Ms Christine G. Salaita, Dr Karim A. Calis, Dr Michael W. Jann, Dr Vicky E. Spratlin, Dr Joyce A. Goldstein and Dr Yuen Yi Hon

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270006287588

  8. Effects of neonatal dexamethasone or methylprednisolone on rat growth and neurodevelopment

    Pediatrics International

    Volume 50, Issue 4, August 2008, Pages: 489–494, Ilknur Kilic, 1 Erol Dagdeviren and 1 Ertugrul Kaya 2

    Version of Record online : 17 APR 2008, DOI: 10.1111/j.1442-200X.2008.02588.x

  9. Immunological effects of oral high-dose methylprednisolone in acute optic neuritis and multiple sclerosis

    European Journal of Neurology

    Volume 7, Issue 3, June 2000, Pages: 281–289, F. Sellebjerg, M. Christiansen, J. Jensen and J. L. Frederiksen

    Version of Record online : 9 OCT 2008, DOI: 10.1046/j.1468-1331.2000.00074.x

  10. Pilot Study of the Pharmacokinetics of Methylprednisolone After Single and Multiple Intravenous Doses of Methylprednisolone Sodium Succinate and Methylprednisolone Suleptanate to Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 34, Issue 11, November 1994, Pages: 1109–1115, James J. Ferry, Andrew A. Della-Coletta, Dennis J. Weber and James T. VanderLugt

    Version of Record online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1994.tb01988.x

  11. Cortisol Pharmacodynamic Response to Long-Term Methylprednisolone in Renal Transplant Recipients

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 14, Issue 1, January-February 1994, Pages: 111–118, Kathleen M. Tornatore, Kristine Reed, J. Joseph Walshe and Rocco C. Venuto

    Version of Record online : 18 JAN 2012, DOI: 10.1002/j.1875-9114.1994.tb02795.x

  12. Dose- and time-related effect of troleandomycin on methylprednisolone elimination

    Clinical Pharmacology & Therapeutics

    Volume 32, Issue 2, August 1982, Pages: 166–171, Stanley J Szefler, Manon Brenner, William J Jusko, Sheldon L Spector, Kathleen A Flesher and Elliot F Ellis

    Version of Record online : 18 AUG 1982, DOI: 10.1038/clpt.1982.143

  13. Prophylactic and Delayed Treatment with High-Dose Methylprednisolone in a Porcine Model of Early ARDS Induced by Endotoxaemia

    Acta Anaesthesiologica Scandinavica

    Volume 29, Issue 8, November 1985, Pages: 831–845, T. Borg, B. Gerdin and J. Modig

    Version of Record online : 30 DEC 2008, DOI: 10.1111/j.1399-6576.1985.tb02307.x

  14. Rectal and oral absorption of methylprednisolone acetate

    Clinical Pharmacology & Therapeutics

    Volume 26, Issue 2, August 1979, Pages: 232–239, Dyal C. Garg, John G. Wagner, Ermelinda Sakmar, Donald J. Weidler and Kenneth S. Albert

    Version of Record online : 4 JAN 2016, DOI: 10.1002/cpt1979262232

  15. Altered Methylprednisolone Pharmacodynamics in Healthy Subjects With Histamine N-Methyltransferase C314T Genetic Polymorphism

    The Journal of Clinical Pharmacology

    Volume 46, Issue 4, April 2006, Pages: 408–417, Dr Yuen Yi Hon, Dr William J. Jusko, Dr Vicky E. Spratlin and Dr Michael W. Jann

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270006286434

  16. You have free access to this content
    Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial

    Cancer

    Volume 76, Issue 10, 15 November 1995, Pages: 1821–1828, Vittorio Gebbia, Antonio Testa, Roberto Valenza, Giuseppe Cannata, Maria L. Tirrito and Nicolo Gebbia

    Version of Record online : 29 JUN 2006, DOI: 10.1002/1097-0142(19951115)76:10<1821::AID-CNCR2820761022>3.0.CO;2-Y

  17. Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics

    Clinical Pharmacology & Therapeutics

    Volume 54, Issue 4, October 1993, Pages: 402–414, Kim H Lew, Elizabeth A Ludwig, Mark A Milad, Kathleen Donovan, Elliott Middleton Jr., James J Ferry and William J Jusko

    Version of Record online : 14 OCT 1993, DOI: 10.1038/clpt.1993.167

  18. Kinetics of methylprednisolone and its hemisuccinate ester

    Clinical Pharmacology & Therapeutics

    Volume 37, Issue 5, May 1985, Pages: 502–507, Hartmut Derendorf, Helmut Möllmann, Peter Rohdewald, Jörg Rehder and Ernst Wilhelm Schmidt

    Version of Record online : 13 MAY 1985, DOI: 10.1038/clpt.1985.79

  19. Ketoconazole effects on methylprednisolone disposition and their joint suppression of endogenous cortisol

    Clinical Pharmacology & Therapeutics

    Volume 42, Issue 4, October 1987, Pages: 465–470, Robert J Kandrotas, Richard L Slaughter, Corstiaan Brass and William J Jusko

    Version of Record online : 17 OCT 1987, DOI: 10.1038/clpt.1987.179

  20. Effects of ketoconazole on methylprednisolone pharmacokinetics and cortisol secretion

    Clinical Pharmacology & Therapeutics

    Volume 39, Issue 6, June 1986, Pages: 654–659, Anne M Glynn, Richard L Slaughter, Corstiaan Brass, Robin D'Ambrosio and William J Jusko

    Version of Record online : 2 JUN 1986, DOI: 10.1038/clpt.1986.114